InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Zheng Yongxiang. Director active across 2 companies, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 3 filings have been logged. Activity tracked since 20 July 2026. The latest transaction was disclosed on 20 July 2026 (Purchase). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条